IRON profile · all as-reported value updates
Disc Medicine, Inc. (IRON) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Stockholders' equity | 2021 | 124,841,000 | -64,203,000 | -189,044,000 | -151.43% | revised comparative figure | 0000950170-22-003288 0000950170-24-034432 | 3 filed observations examined for this concept and period. |
| Stockholders' equity | 2020 | 5,000,010 | -28,809,000 | -33,809,010 | -117.36% | revised comparative figure | 0001213900-21-018272 0000950170-23-011139 | 3 filed observations examined for this concept and period. |
| Assets | 2020 | 122,092,565 | 8,319,000 | -113,773,565 | -93.19% | revised comparative figure | 0001213900-21-018272 0000950170-22-003288 | 2 filed observations examined for this concept and period. |
| Liabilities | 2020 | 4,823,815 | 30,180,000 | 25,356,185 | +84.02% | revised comparative figure | 0001213900-21-018272 0000950170-22-003288 | 2 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2020 | 1,212,084 | 4,503,000 | 3,290,916 | +73.08% | revised comparative figure | 0001213900-21-018272 0000950170-22-003288 | 2 filed observations examined for this concept and period. |
| Operating income | 2021 | -69,002,000 | -30,933,000 | 38,069,000 | +55.17% | revised comparative figure | 0000950170-22-003288 0000950170-23-011139 | 2 filed observations examined for this concept and period. |
| Operating cash flow | 2021 | -59,700,000 | -27,534,000 | 32,166,000 | +53.88% | revised comparative figure | 0000950170-22-003288 0000950170-23-011139 | 2 filed observations examined for this concept and period. |
| Net income | 2021 | -71,869,000 | -35,969,000 | 35,900,000 | +49.95% | revised comparative figure | 0000950170-22-003288 0000950170-23-011139 | 2 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2021 | 136,627,000 | 88,036,000 | -48,591,000 | -35.56% | revised comparative figure | 0000950170-22-003288 0000950170-23-011139 | 2 filed observations examined for this concept and period. |
| Assets | 2021 | 140,437,000 | 92,411,000 | -48,026,000 | -34.20% | revised comparative figure | 0000950170-22-003288 0000950170-23-011139 | 2 filed observations examined for this concept and period. |